Check Cap Ltd (NASDAQ:CHEK) shares saw strong trading volume on Friday . 4,661,692 shares changed hands during mid-day trading, an increase of 633% from the previous session’s volume of 635,844 shares.The stock last traded at $2.77 and had previously closed at $2.44.

Several analysts have recently issued reports on the company. Maxim Group increased their price objective on Check Cap from $6.00 to $11.00 and gave the company a “buy” rating in a research note on Monday. Zacks Investment Research cut Check Cap from a “buy” rating to a “hold” rating in a research note on Wednesday, July 20th. Finally, Chardan Capital reduced their price objective on Check Cap from $6.00 to $4.00 and set a “buy” rating on the stock in a research note on Friday, May 20th.

The company’s market cap is $40.24 million. The stock’s 50 day moving average is $1.36 and its 200 day moving average is $2.23.

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.